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Background: The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach has
been adopted by many national and international organisations as a systematic and transparent framework for
evidence-based guideline development. With reference to an ongoing debate in the literature and within public
health organisations, this study reviews current experience with the GRADE approach in rating the quality of
evidence in the field of public health and identifies challenges encountered.
Methods: We conducted semi-structured interviews with individuals/groups that have applied the GRADE
approach in the context of systematic reviews or guidelines in the field of public health, as well as with
representatives of groups or organisations that actively decided against its use. We initially contacted potential
participants by email. Responses were obtained by telephone interview or email, and written interview summaries
were validated with participants. We analysed data across individual interviews to distil common themes and
challenges.
Results: Based on 25 responses, we undertook 18 interviews and obtained 15 in-depth responses relating to
specific systematic reviews or guideline projects; a majority of the latter were contributed by groups within the
World Health Organization. All respondents that have used the GRADE approach appreciated the systematic and
transparent process of assessing the quality of the evidence. However, respondents reported a range of minor and
major challenges relating to complexity of public health interventions, choice of outcomes and outcome measures,
ability to discriminate between different types of observational studies, use of non-epidemiological evidence,
GRADE terminology and the GRADE and guideline development process. Respondents’ suggestions to make the
approach more applicable to public health interventions included revisiting terminology, offering better guidance
on how to apply GRADE to complex interventions and making modifications to the current grading scheme.
Conclusions: Our findings suggest that GRADE principles are applicable to public health and well-received but also
highlight common challenges. They provide a starting point for exploring options for improvements and, where
applicable, testing these across different types of public health interventions. Several public health organisations are
currently testing GRADE, and the GRADE Working Group is eager to engage with these groups to find ways to
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Public health interventions affect large population groups
and can generate significant health benefits at individual
and population levels. Even though many public health
approaches are preventive in nature, intervening in people’s
lives may nevertheless do harm as well as good. In addition,
they consume both financial and human resources, and
may compromise individual freedom of choice. Public
health interventions range from programmatic activities
that initiate direct, proximal changes in a specific techno-
logy or behaviour to those that bring about more distal
changes in multi-sectoral policies with indirect impacts on
health [1]. These interventions often combine several
approaches that are designed by and delivered through
the health sector and/or other sectors [2].
Evaluating public health interventions is far from
straightforward and there is much discussion as to how
evidence should be gathered, synthesised and used in deci-
sion making [3-9]. Developing recommendations or poli-
cies in public health relies on complex judgements about
a range of factors including magnitude of the health prob-
lem, benefits and harms of a given intervention, use of
personnel and financial resources, transferability, as well
as intervention acceptability and feasibility. Making the
decision-making process explicit and transparent is criti-
cal, as is a careful examination of the types of evidence
underlying specific judgements and, in particular, the
quality of evidence in support of likely benefits and harms.
Public health organisations in different countries have
developed distinct approaches to convey the quality of
the evidence [10].These include the Guide to Community
Preventive Services (Community Guide) issued by the
United States Community Preventive Services Task Force
[11,12], Public Health Guidance developed by the
National Institute for Health and Clinical Excellence
(NICE) [13] and the Netherland’s Organisation for Public
Health’s recognition system for health promotion inter-
ventions [14,15]. While, to our knowledge, these have not
been formally compared, the use of many different schemes
in parallel may lead to a divergent rating of the quality of
evidence and conflicting recommendations. This may hin-
der the goal of helping guideline developers and policy-
makers make well-informed decisions in a transparent way,
both nationally and internationally [16].
The Grading of Recommendations Assessment, Deve-
lopment and Evaluation (GRADE) Working Group, a
network of primarily clinical guideline developers and sys-
tematic reviewers, has attempted to meet this challenge by
developing and testing a rigorous, systematic and trans-
parent framework for evidence-based guideline develop-
ment [17-19]. In a first step, the quality of the evidence
(defined as the extent of our confidence that the estimate
of effect is correct and/or that this estimate is adequate to
support a particular recommendation) is classified in oneof four categories: high, moderate, low or very low quality
[20,21]. Randomised controlled trials begin as high qua-
lity, while observational study designs (including non-
randomised or quasi-randomised intervention studies as
well as cohort studies, case control studies and other
correlational study designs) begin as low quality. The
quality of the evidence can subsequently be rated down
based on five criteria (i.e. risk of bias, inconsistency,
indirectness, imprecision, publication bias) or rated up
based on three criteria (i.e. strong association, dose-
response gradient, plausible confounding). In a second
step, the strength of a recommendation (defined as the
extent to which we can be confident that desirable
effects of an intervention outweigh undesirable effects)
is graded as either strong or weak (conditional or dis-
cretionary). This judgement of the strength of a recom-
mendation is based on magnitude of desirable and
undesirable consequences, quality of evidence, values
and preferences and resource use.
More than 65 national and international organisations
have adopted the GRADE approach (see http://www.gra-
deworkinggroup.org/society/). While the GRADE Working
Group promotes the use of the framework across clinical
and non-clinical health evidence, there has been much
debate in the literature [22-28] and within public health
organisations (e.g. European Centre for Disease Prevention
and Control, Swedish National Institute of Public
Health, Canadian Public Health Agency, World Health
Organization) as to whether this scheme is well-suited
to public health interventions.
As a contribution to this debate, the objectives of this
study were to review current use of and experience with
the GRADE approach in rating the quality of evidence
in the field of public health, and to identify challenges
encountered.
Methods
We conducted semi-structured interviews with two
groups: individuals that have applied the GRADE ap-
proach in the context of systematic reviews or guidelines
in the field of public health and selected individuals
representing public health organisations that actively
decided against the use of the GRADE approach. Both
groups, given their familiarity with the GRADE app-
roach, are in principle in a position to report specific
challenges encountered, with semi-structured interviews
providing room for open, in-depth feedback. In addition,
we attempted to document whether organisations known
to develop evidence-based public health guidance have
adopted the GRADE approach or not, although this was
not undertaken in a systematic way.
Public health interventions were classified a priori as
(i) health policy, (ii) health system (iii) behavioural, (iv)
nutrition, (v) environmental, (vi) vaccination and (vii)
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gory clinical interventions, as several answers provided
by respondents related to treatment guidelines.
We primarily identified potential participants through
the recommendations of members of the GRADE Working
Group and the Guidelines Review Committee at the World
Health Organization. We also approached the Cochrane
Collaboration’s Public Health Group, the Cochrane
Collaboration’s Effective Practice and Organisation of
Care Group, the Campbell Collaboration, the SUPPORT
collaboration through the Norwegian Knowledge Centre
for the Health Services, the Public Health Agency of
Canada, the Swedish National Institute of Public Health,
the United States Community Preventive Services Task
Force, the European Centre for Disease Prevention and
Control and the NICE Centre for Public Health Excellence
in the United Kingdom.
We initially contacted potential participants by email
with up to two email reminders as needed, inviting them
to share their experience with applying the GRADE
approach. We asked respondents the following three
open-ended questions, and encouraged them to provide
specific examples to illustrate their responses:
 What are the challenges encountered in applying
the GRADE approach to rating evidence for public
health interventions?
 Does the evidence grade obtained through GRADE
adequately reflect the confidence in the evidence?
 Could fine-tuning of the existing rating of evidence
make the GRADE approach more applicable to
public health interventions?
In most cases, answers were obtained by telephone
interview; in the remaining cases, answers were sum-
marised based on email correspondence. We established
experience with the use of GRADE for each interview as
(i) applied without significant challenges, (ii) applied
with minor challenges, (iii) applied with major chal-
lenges, (iv) currently being considered/tested, and (v)
not currently applied. Specific challenges encountered
and suggestions to change the existing rating of the evi-
dence were initially identified by ER from written, vali-
dated summaries of individual interviews. These were
then analysed across individual interviews by ER and EA
to distil broader common themes.
In order to validate our findings, we asked each partici-
pant to review and correct written summaries of the inter-
views and our rating of her/his experience with the
application of GRADE. As necessary, we approached par-
ticipants up to three times for validation. At a later stage,
we also shared the draft paper with all participants and a
wide range of interested parties to obtain feedback on our
interpretation of findings. The study was acknowledged bythe ethics committee at the University of Munich; ethics
approval was not required.
Results
Of 29 individuals/groups in 12 organisations that were
approached, 4 did not respond. Table 1 lists the orga-
nisation, the group within the organisation, the rating of
their use of GRADE or lack of GRADE endorsement,
and the number of in-depth responses. 15 interviews
were undertaken with individuals/groups that had
applied GRADE in one or more systematic review or
guideline projects and provided in-depth responses on
their experiences (Additional file 1). An additional
3 interviews were conducted with individuals/groups
that were familiar with GRADE but actively decided
against using the approach. The remaining 7 responses
were recorded but did not lead to in-depth interviews
(Table 1).
What are the challenges encountered in applying the
GRADE approach to rating evidence for public health
interventions?
Detailed responses to this question among the indivi-
duals/groups who had applied GRADE in one or more
systematic review or guideline projects (Additional file 1)
can be summarised as GRADE is applied without signi-
ficant challenges (2 responses), GRADE is applied with
minor or major challenges (12 responses) and GRADE is
currently being tested (1 response) (Table 1). As is illus-
trated in Table 2, GRADE has been applied across a range
of public health interventions.
Two individuals/groups reported no significant chal-
lenges in applying GRADE. They emphasised that it offers
an explicit, transparent, rigorous and flexible process that
forces systematic reviewers and guideline developers to
consider limitations in the evidence base. It brings objec-
tivity to the guideline development process from formula-
ting the question to appraising evidence to deriving a
recommendation.
Twelve individuals/groups reported challenges in ap-
plying GRADE. More than half of them described these
challenges as minor (i.e. challenges in relation to exact
interpretation of GRADE criteria, challenges with res-
pect to GRADE application), the other half suggested
that these were major (i.e. introduction of new GRADE
criteria, use of observational and non-epidemiological
evidence). Even among the groups reporting challenges
general feedback about the GRADE approach was posi-
tive. Users emphasised that GRADE principles apply to
public health interventions, appreciated the systematic
and transparent process of assessing the quality of
evidence and stated that the GRADE approach has
improved the quality of guideline development.
Specific challenges reported can be grouped as follows:
Table 1 Overview of organisations approached and responses obtained






Cochrane Collaboration Effective Practice and Organisation
of Care Group
1 GRADE applied without
significant challenges
0
Public Health Group 1 GRADE endorsed and
currently being tested
1
Campbell Collaboration Methods Group 1 GRADE not currently
applied
0
World Health Organization HIV/AIDS 1 GRADE applied without
significant challenges
1
Tuberculosis 1 GRADE applied with minor
challenges
1
Nutrition for Health and
Development
1 GRADE applied without
significant challenges
1
Maternal, Newborn, Child and
Adolescent Health





1 GRADE applied with minor
challenges
1
Mental Health 1 GRADE applied with major
challenges
1
Public Health and Environment 2 GRADE applied with major
challenges
1
Health Systems and Services 1 GRADE applied with minor
challenges
1
Reproductive Health and Research 1 GRADE applied with minor/
major challenges
1
Public Health Agency of Canada Centre for Chronic Disease
Prevention and Control
1 GRADE currently being
tested
0
Canadian Guidelines for Immigrant
Health
- 1 GRADE applied with minor
challenges
1
Canadian Task Force on Preventive
Health Care
- 1 GRADE applied with major
challenges
1
Swedish National Institute of Public
Health
Department of Child and Elderly
Health




Preventive Services Task Force
Centers for Disease Control and
Prevention, Community Guide
Branch
1 GRADE not currently
applied
0
European Centre for Disease
Prevention and Control
Office of the Chief Scientist 1 GRADE not currently
applied
0
National Institute for Health and
Clinical Excellence, United Kingdom
Centre for Public Health Excellence 1 GRADE not currently
applied
0
Norwegian Knowledge Centre for
the Health Services
SUPPORT network 3 GRADE applied with minor
challenges
2
Boston University Centre for Psychiatric Rehabilitation 1 GRADE not currently
applied
0
Total - 25 - 15
Minor challenges: no major concerns, challenges in relation to exact interpretation of GRADE criteria and challenge with respect to GRADE application.
Major challenges: major concerns, introduction of new GRADE criteria, use of observational and non-epidemiological evidence.
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Public health interventions tend to be complex with
several components. In principle, studies assessing
these interventions may look at one, all or different
combinations of these components although, in
practice, most evaluations focus on the impact of
the whole package. Guideline developers andsystematic reviewers developing a PICO
(i.e. population, intervention, comparison, outcome)
question for a specific intervention need to either
consider the intervention as a whole or focus on a
presumed active component. Either decision
presents challenges regarding which studies to
include or exclude, how to interpret heterogeneity,
Table 2 Overview of specific topics covered, classified by intervention type
Type of intervention Topics covered
Health policy
interventions
SUPPORT summary: Do pharmaceutical reference and index pricing policies have effects on drug use, health care
utilisation, health outcomes and costs?
Health systems
interventions
WHO guideline on prevention and treatment of HIV and other sexually transmitted infections among men who have sex
with men and transgender people
WHO guideline on retention of rural health workers
Various WHO guidelines on community-based newborn care
SUPPORT summary: Do conditional cash transfers improve the uptake of health interventions in low and middle-income
countries?
SUPPORT summary: Does pay-for-performance improve the quality of health care?
SUPPORT summary: Does expanding the role of outpatient pharmacists improve healthcare delivery and patient
outcomes?
SUPPORT summary: Does prompting physicians improve performance in preventive care?
Nutrition interventions Guideline: Neonatal vitamin A supplementation
Guideline: Vitamin A supplementation for infants 1–5 months of age
Guideline: Vitamin A supplementation for infants and children 6–59 months of age
Guideline: Vitamin A supplementation in pregnant women
Guideline: Vitamin A supplementation in postpartum women
Guideline: Vitamin A supplementation during pregnancy for reducing the risk of mother-to-child transmission of HIV
Guideline: Intermittent iron supplementation in preschool and school-age children
Guideline: Intermittent iron and folic acid supplementation in menstruating women
Guideline: Daily iron and folic acid supplementation in pregnant women (in press)
Guideline: Intermittent iron and folic acid supplementation in non-anaemic pregnant women (in press)
Guideline: Use of multiple micronutrient powders for home fortification of foods consumed by infants and children 6–23
months of age
Guideline: Use of multiple micronutrient powders for home fortification of foods consumed by pregnant women
WHO recommendations for prevention and treatment of pre-eclampsia
WHO guidelines on HIV and infant feeding
Behavioural
interventions
Canadian physical activity and sedentary guidelines for the early years
Environmental
interventions
WHO indoor air quality guidelines: household fuel combustion (ongoing)
Cochrane systematic review on housing improvements for health and associated socioeconomic outcomes (ongoing)
Vaccination Cholera vaccines: WHO position paper
Hepatitis B vaccines: WHO position paper
Human papillomavirus vaccines: WHO position paper
Measles vaccines: WHO position paper
Meningococcal vaccines: WHO position paper
Pertussis vaccines: WHO position paper
Pneumococcal vaccines: WHO position paper
Polio vaccines and polio immunization in the
pre-eradication era: WHO position paper
Rabies vaccines: WHO position paper
Rubella vaccines: WHO position paper
Vaccines against tick-borne encephalitis: WHO position paper
Screening interventions Guidelines on cervical cancer screening
Guidelines on breast cancer screening
Guidelines on latent TB screening among immigrants and refugees
Guidelines for hepatitis B screening among immigrants and refugees
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Table 2 Overview of specific topics covered, classified by intervention type (Continued)
Clinical interventions WHO guidelines for the programmatic management of drug-resistant tuberculosis
WHO guidelines for mental health, neurological and substance use disorders within WHO Mental Health Gap Action
Programme
WHO guidelines on prevention and control of cervical cancer (ongoing)
WHO guidelines on the management of children with severe malnutrition
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degree of indirectness.
 Choice of outcomes and outcome measures:
Most respondents emphasised that the choice of
outcomes and outcome measures tends to be
complicated in systematic reviews of public health
interventions due to (i) multiple outcomes for most
interventions, (ii) outcomes at individual and group
levels, (iii) reliance on short-term surrogate rather
than morbidity and mortality outcomes that are
significantly delayed into the future, (iv) inconsistencies
associated with the use of competing measures or
assessment scales and (v) the need to group
heterogeneous measures under “umbrella outcomes”
to make the review policy-relevant. The choice of
outcome and outcome measures has implications for
indirectness of evidence and needs to be decided on
and judged carefully as part of the GRADE process.
 Ability to discriminate between different types of
observational studies: Many groups reported
difficulty using GRADE to rate public health
evidence derived from observational studies. With
the quality of evidence for all types of non-
randomised studies starting as low, the GRADE
approach is perceived as lacking the ability to
distinguish between those public health
interventions that are reasonably well-supported by
evidence (e.g. by interrupted time series studies) and
those that are less supported by evidence (e.g. by
cohort studies). This may lead to misinterpretations
of the evidence when communicating the message
to policy-makers, and may even discourage the
conduct of “best possible” studies. The GRADE
approach should encourage people to develop and
make the best use of high-quality evidence and not
lead to an unrealistic restriction of the evidence,
even if unintended.
 Use of non-epidemiological evidence: Several groups
also noted that the GRADE approach does not allow
users to integrate non-epidemiological evidence,
such as laboratory, mechanistic or animal studies,
the principles of other disciplines (e.g. physiology,
engineering, toxicology, chemistry, physics) and
evidence on implementation and context. All of
these can be critical when assessing the effectiveness
of a public health intervention (e.g. as individualsare exposed to air pollution indoors as well as
outdoors, a whole-village implementation approach
for improved cookstoves will show much greater
reductions in household air pollution and
respiratory health outcomes than a single-household
implementation approach), as well as when making
a recommendation concerning implementation.
As one respondent put it, ”relying solely on
epidemiological evidence to assess intervention
effectiveness is imprudent, as there are many factors
influencing the results beyond whether or not the
principle of a technology works.”
 GRADE terminology: Several groups stated that
some of the GRADE terminology and definitions
were not appropriate for public health interventions
(e.g. definition of quality of evidence, use of the
terms patients and clinicians). They also expressed
concern about possible misinterpretations by
policy-makers of “low quality evidence” and/or
“weak recommendations”, with such wording
potentially being used to justify inaction. Likewise,
GRADE uses the term “observational study” to refer
to all studies that are not randomised. In the public
health world, the major distinction tends to be
between observational studies where the assignment
of individuals/clusters to an exposed/intervention
group vs. unexposed/control group is outside of the
control of the investigator (e.g. case–control, cohort,
cross-sectional, patient series, time series) and those
where the assignment of individuals/clusters to an
intervention vs. control group is undertaken by the
investigator in a randomised or non-randomised
fashion (e.g. individually randomised, cluster-
randomised trials, quasi-/pseudo-randomised trials,
controlled before-and-after studies). Possibly as a
result of this confusion in terminology some
guideline projects have quasi-experimental designs
begin as high followed by downgrading rather than
having these begin as low followed by upgrading, as
recommended by the GRADE approach.
 GRADE and guideline development process:
Several respondents mentioned that GRADE is often
applied to systematic reviews that do not consider
all relevant data, in part because including non-
randomised study designs makes the systematic
review process methodologically challenging and
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systematic review are very heterogeneous and effect
estimates cannot be pooled, applying GRADE
criteria (e.g. inconsistency, imprecision, magnitude
of effect, publication bias) to narrative estimates of
impact becomes challenging. Some respondents also
noted that the GRADE approach was not
sufficiently objective and reproducible. Many
respondents suggested that the GRADE process for
going from evidence to recommendations was both
difficult and ad hoc in terms of taking into
consideration values and preferences, cost
effectiveness and feasibility issues (e.g. characteristics
of delivery agents or systems, availability of
implementation studies). Finally, there were
concerns about the major financial and human
resources required.
The United States’ Community Guide and the Pub-
lic Health Guidance offered by the United Kingdom’s
NICE Centre for Public Health Excellence are often
referred to as models for evidence-based public health
decision-making. Both organisations explicitly decided
against using the GRADE approach:
• We perceive challenges in applying GRADE to the
types of evidence we commonly use in the
development of recommendations – these often
include observational studies for questions of
effectiveness and other types of studies for answering
a range of other questions, such as qualitative
research about the views of service users. We also use
observational studies to help identify potential barriers
to implementation. Further, as well as considering the
quality, strength and applicability of the evidence, our
committees take into account cost effectiveness,
ethics, equity and other issues in developing
recommendations. We think our current system gives
us the flexibility we need, given the breadth of public
health topics, the types of questions and the range of
outcomes considered.” (Simon Ellis, NICE Centre for
Public Health Excellence, United Kingdom)
• At the Community Guide we do not use GRADE
because we do not believe it works well when applied
to population-level interventions. Specifically, it does
not adequately differentiate between quasi-
experimental designs with differing degrees of
protection against threats to internal validity, and
hence undervalues the evidence from the strongest of
these designs. It is particularly problematic when
there are many studies for which the most plausible
threats to validity are expected to be randomly
distributed, rather than systematically biasing theresults in one direction.“ (Randy Elder, Community
Guide Branch, United States Centers for Disease
Control and Prevention)
Similarly, having explored its use, the Center for
Psychiatric Rehabilitation at Boston University actively
rejected the GRADE approach:
• Interventions in the field of psychiatric disability and
mental illness are characterised by complexity, as they
critically rely on interactions between two or more
human beings, as well as social groups. In view of
small sample sizes available, the typical course of
exacerbations and remissions for many mental
illnesses, and issues associated with role performance
and societal integration outcomes, RCTs are very
difficult to conduct. Therefore, the majority of studies
in our field, with some notable exceptions, have been
correlational, observational or quasi-experimental to
this point. Given that GRADE, from the outset,
determines observational studies to be of low quality,
we felt that we had to begin from the question – what
standards would properly assess such studies and
their findings in terms of scientific rigor and meaning,
rather than assessing them against a standard that
they would rarely be able to meet. As a result, we
developed our own grading systems for such studies.”
(Marianne Farkas, Center for Psychiatric
Rehabilitation, Boston University)
Does the evidence grade obtained through GRADE
adequately reflect the confidence in the evidence?
Most respondents felt that the evidence grade obtained by
applying GRADE to their systematic review or guideline
project was appropriate. They stated that the application
of the GRADE criteria had opened their eyes to important
limitations in the underlying evidence base. At the same
time, they expressed the following concerns:
 Meaning of confidence in the evidence: GRADE
defines quality of evidence as confidence in the
pooled effect estimate. As the effectiveness of public
health interventions is critically influenced by modes
of delivery and contextual issues, a more relevant
interpretation would be “confidence that the effect is
meaningful across a range of plausible
implementation contexts” (Randy Elder, Community
Guide Branch, United States Centers for Disease
Control and Prevention)
 Selection of the appropriate body of evidence for
rating can be difficult: Several groups stated that it is
challenging to grade the quality of evidence, in the
presence of both a single or few randomised studies
(rated as high quality, not downgraded for
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non-randomised studies (rated as low quality,
potentially downgraded for inconsistency and
reporting bias). In the extreme case, can one
well-conducted and large RCT conducted in one
setting and rated as high-quality be sufficient to
decide on the effectiveness of a complex
intervention that critically relies on context?
 All observational study designs begin as low-quality
evidence: A number of participants stated that the
current approach does not appropriately
discriminate between stronger and weaker
observational study designs. They suggested that
quasi-experimental designs, interrupted time series
studies and self-controlled case series should begin
as moderate quality. In fact, some respondents felt
that applying the GRADE criteria resulted in
multiple discriminations against observational
studies, where these studies started off low and were
at risk of being penalised once more for threats to
validity inherent to their design.
 There are insufficient possibilities for upgrading
observational studies: Different groups suggested a
broader interpretation of existing criteria, such as
extending the concept of dose–response to the
population level, and the addition of new criteria for
upgrading, in particular consistency and analogy.
While GRADE allows for the downgrading of a body
of evidence for inconsistency, consistency in findings
across different settings, study designs and research
groups actually increases our confidence in the
evidence, as already stated by Sir Austin Bradford
Hill. Analogy extends the concept of consistency to
parallel evidence from related risk factors,
interventions or population groups.
 Non-epidemiological evidence can only be rated as very
low-quality: Judging the effectiveness of a public
health intervention sometimes relies on sources of
evidence outside of epidemiology. Physiological,
physical or engineering principles and the insights
gained through laboratory or animal studies can
only be brought into the rating exercise as a
separate very low-quality piece of evidence rather
than lending additional credibility to epidemiological
evidence. GRADE also lacks a structured approach
for integrating evidence on implementation and
context, issues that often directly impact the
effectiveness of complex interventions.
Could fine-tuning of the existing rating of evidence make
the GRADE approach more applicable to public health
interventions?
As has been apparent in previous sections, respondents
did not limit their comments to rating the quality ofevidence but provided feedback on the GRADE ap-
proach overall. Here, we focus on suggestions for fine-
tuning the rating step; more general feedback has
already been reported above. Suggestions by respondents
largely fall into two categories and reflect comments dis-
cussed above: pragmatic guidance on the application of
the GRADE approach for complex interventions and
modifications to the existing GRADE criteria.
Respondents expressed uncertainty about and requested
pragmatic guidance on:
 How to reflect intervention complexity in rating
quality of evidence, in view of much of the available
primary studies and systematic reviews simplifying
intervention complexity;
 How to prioritise individual vs. group level
outcomes, short term vs. longer term outcomes and
surrogate vs. morbidity and mortality outcomes, as
differences in prioritisation are likely to impact the
evidence rating;
 How to decide whether very limited randomised
evidence is sufficient or not, as including non-
randomised evidence will have an impact on how
the quality of evidence is rated;
 How to ensure reproducibility in rating the quality
of evidence, both in relation to individual GRADE
criteria and their integration; and
 How to apply the GRADE criteria to narrative
summaries.
Respondents also proposed specific modifications to
rating the quality of evidence:
 That selected observational study designs start off as
moderate in order to discriminate more accurately
between different levels of internal validity;
 That additional criteria for upgrading be developed
and operationalised, as these would allow confidence
in a body of observational evidence to be reflected
more accurately;
 That a systematic approach for incorporating
non-epidemiological evidence that directly relates to
intervention effectiveness be developed; and
 That a systematic approach for assessing the quality
of modelling studies be considered.
Discussion
Key findings
The objective of this study was to review the current use of
and accumulating experience with the GRADE approach
in rating the quality of evidence in the field of public
health, and to identify challenges encountered to date. Des-
pite the challenges reported, it is important to note that all
respondents that have employed GRADE in a systematic
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transparent process of assessing the quality of evidence.
This highlights that the general principles of the approach
are both suitable to public health and well-received.
Common themes emerged with respect to aspects of
the GRADE approach in its current form lacking appli-
cability, reproducibility and clarity in the field of public
health. Specific challenges related to (i) complexity of
public health interventions, (ii) choice of outcomes and
outcome measures, (iii) ability to discriminate between
different types of observational studies, (iv) use of non-
epidemiological evidence, (v) GRADE terminology and
(vi) the GRADE and guideline development process.
Respondents also made suggestions for additional prag-
matic guidance and specific modifications to rating the
quality of evidence; these are integrated in the below pro-
posal towards making the GRADE approach more appli-
cable to public health interventions.
Several of the challenges reported are not specific to
GRADE per se but relate more to the process of systema-
tically reviewing and synthesising complex public health
evidence; by requiring a transparent and structured ap-
proach for rating the quality of evidence and grading the
strength of a recommendation, GRADE makes these
challenges salient. In particular, the guideline develop-
ment process often relies on systematic reviews that
do not consider all relevant data, that are based on
very heterogeneous data and that conclude with nar-
rative syntheses rather than meta-analyses. Some of
these issues are revisited in more detail below. Also,
while it is argued that use of the GRADE approach
substantially increases financial and human resource
costs, a majority of these additional resources is likely
to be required for conducting systematic reviews ra-
ther than for the application of GRADE.
It is noteworthy that the majority of specific GRADE
applications in the field of public health to date appear to
have taken place at the World Health Organization where
the use of GRADE has been mandatory since 1 January
2009. GRADE is also used as part of the SUPPORT
Collaboration and at the Norwegian Knowledge Centre
for the Health Services, which acts as one of the satellites
for the Cochrane Collaboration’s Effective Practice and
Organisation of Care Group. This rather limited experi-
ence with GRADE in the public health field begs the
question whether this research was conducted ahead
of its time, or whether the added value of the
GRADE approach to public health beyond current
practices is not sufficiently apparent. The fact that
several groups are currently testing GRADE (Table 1)
and that some of those groups who explicitly decided
against use of GRADE expressed an interest in the
results of this study and are, in principle, willing to
revisit their decision suggests that this study is timely.Complexity of public health interventions revisited
Several respondents reported difficulties in applying
GRADE that relate to complexity of public health inter-
ventions, e.g. their proactive, multi-component nature,
a focus on the population level, a multiplicity of rele-
vant outcomes and influence of implementation mode
and context on effectiveness. Table 3 suggests an
extended PICO approach that systematically notes key
differences between “simple” and “complex” interven-
tions. Please note that we avoid a distinction between
clinical and public health interventions, as both types
of interventions tend to be located along a spectrum of
complexity, i.e. many of the concerns are not unique to
public health interventions but equally apply to com-
plex clinical interventions.
There is increasing recognition that complex preventive
or curative interventions should be developed and tested
using a theory-driven, phased approach [3,29-31], which
somehow mimics the sequential phases of drug develop-
ment. To date, however, public health interventions that
follow this approach are rare, which means that evidence-
based decision-making continues to rely on systematic
reviews that evaluate the effectiveness of an amalgam of
interventions combining components that vary in number,
quality and intensity. Unfortunately, small sample sizes in
some categories did not allow us to explore more formally
how the GRADE experience varies in relation to interven-
tion complexity, where on average health policy, health
systems or environmental health interventions tend to be
more complex than clinical, screening or vaccination
interventions (Table 2). Yet, it is apparent from Table 3
that a more or less complex interpretation of these inter-
ventions will have implications for how systematic reviews
are scoped and conducted, and for how their findings
are rated; while a simple interpretation of many clinical
interventions is commonly performed and often pro-
vides adequate insight, a simple interpretation of many
public health interventions can be misleading (Rehfuess
and Bartram, work in progress).
Several respondents suggested that the GRADE ap-
proach does not do justice to the insights to be gained
from well-conducted non-randomised studies. These are
part and parcel of public health evidence, as sometimes
RCTs are either not feasible (e.g. pricing of tobacco pro-
ducts, advertising bans for alcohol) or not appropriate
where an intervention has multiple or indirect health
impacts, where impacts materialise in a gradual or delayed
fashion, and where an intervention is so complex that
RCT results will be unacceptably artificial [5,32]. Indeed,
natural experiments are increasingly recommended as a
suitable way of understanding the health impacts of large-
scale population health interventions [4]. One respondent
went as far as describing a “three-level discrimination
against observational study designs” throughout the
Table 3 Comparison of “simple” and “complex” interventions
“Simple” interventions “Complex” interventions
Population Sick population seeking care Healthy general or at-risk population
Intervention Individual-level intervention Population- and/or individual-level intervention
Single component Multiple interacting components
“Reactive” treatment through medication or surgery or
clinical prevention
“Proactive” prevention through behaviour change and/or technical
intervention and/or policy
Implementation in healthcare setting Implementation in household, community or policy setting
Comparison No intervention or alternative intervention through
treatment/surgery
“Business as usual” in several sectors
Outcome Shorter causal pathway Longer causal pathway
One or a small number of health outcomes Multiple health outcomes and broader societal consequences
Usually impact after short lag period Usually impact after long lag period
Delivery of
intervention
Delivery through health sector Delivery through multiple sectors
Contextual
effects
Variation between healthcare providers (individuals,
institutions)
Variation between providers of different intervention components in
multiple sectors
Patient preference and compliance Large cultural and behavioural variation
“Simple interventions” tend to show more of the characteristics in the left column while “complex” interventions tend to show more of those in the right column.
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First, those interventions that are difficult to study
through RCTs, as described by the “inverse evidence law”
(i.e. there tends to be greater quantity and better-quality
evidence for simple interventions directed at individuals
compared to complex interventions directed at populations
[33,34]), are less likely to be the subject of a primary evalu-
ation or a systematic review. Secondly, when systematic
reviews are conducted, they often search the literature only
for randomised designs, dismissing as noise much of what
others would consider to be the signal. Thirdly, when evi-
dence is graded, all observational studies start off as low-
quality independent of the greater or lesser internal validity
of the specific study design.
Evidence-based public health guidance also needs to
draw on sources of evidence beyond the traditional hie-
rarchy of epidemiological study designs. First, public
health evidence is never context-free [9], and the im-
portance of capturing information on intervention deli-
very, economics, equity and the overall socio-economic
environment in systematic reviews has been previously
emphasised [35]. Secondly, public health is multidiscip-
linary and multi-sectoral by definition, and thus relies
on broader sources of evidence, including “parallel evi-
dence” [36] from related risk factors, interventions or
population groups, which may strengthen overall con-
fidence in the quality of the evidence. As of yet, the
GRADE approach does not offer a framework for syste-
matically appraising and integrating contextual evidence
and evidence generated by disciplines other than epi-
demiology. A causal-chain approach, where evidence
assessments take place across sequential links, where
some links are amenable to GRADE in its current formwhereas others are not, might offer a starting point
(Bruce et al, work in progress).
Strengths and limitations of study
This study is not representative of all GRADE applications
in the field of public health to date. While we approached
a large number of organisations and individuals, we may
have overlooked others, and therefore potentially missed
relevant insights. Although we obtained responses from
all organisations approached, some groups or individuals
within those organisations did not respond to our three
emails to establish initial contact.
Moreover, the characteristics of those interviewed vary
greatly, for example in relation to level of epidemiological
training, depth and breadth of the GRADE experience
(i.e. number of specific GRADE applications and across
different GRADE versions) and the level of support
received from the GRADE Working Group. As a result,
the classification of challenges as minor or major may not
be directly comparable. On the other hand, our sample
encompasses a range of organisations, health issues
(e.g. communicable diseases, non-communicable dis-
eases, health systems) and types of public health inter-
ventions, offering the full breadth of experiences to
date. Therefore, we believe that this study offers im-
portant insights into issues that several organisations
and groups are currently struggling with.
While interview summaries and their qualitative inter-
pretation are inherently subjective we had summaries
validated and provided all participants with an oppor-
tunity to review the draft manuscript. Also, the fact that
our empirical approach and the group of experts con-
vened by the European Centre for Disease Prevention
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encouraging:
 The GRADE approach is limited to assessing the
level of evidence for the efficacy/effectiveness of an
intervention, while prioritisation of topics, selection
of experts and dealing with potential conflicts of
interest should also be handled in a systematic,
explicit and transparent manner.
 The GRADE approach employs nomenclature to
describe the confidence in the level of evidence that
may sound pejorative, such as “low quality”; more
neutral terminology would be more appropriate.
 The GRADE approach appears to have too few
categories to capture different levels of evidence
represented by study designs beyond randomised
controlled trials.
 The GRADE approach is very limited in its
applicability to other types of evidence, such as
microbiological investigations, health economic
models, mathematical models of the spread of
infectious diseases and incidence/prevalence studies.
 The GRADE approach includes too few criteria for
upgrading the quality of observational studies.
 The GRADE approach is limited in its applicability to
issues beyond the assessment of efficacy/effectiveness
(and possibly safety) of interventions, such as risk
assessment, disease causation and spread of infectious
diseases.
 The GRADE approach is time-consuming and may
thus not be suitable for a rapid grading of evidence
under time pressure.
 The GRADE approach does not appear to perform
well in situations of scarce evidence that often
characterise the field of public health.
 The GRADE approach does not appropriately
address going from evidence to recommendations,
which should also include considerations of context,
law, ethics, economic and political considerations.A proposal towards improving GRADE’s applicability to
public health interventions
Some groups have shown that finding solutions to many
of these challenges within the current version of GRADE
is possible [37], others are already implementing some of
the proposed changes [22-24]. If GRADE is to remain a
standardised approach, it is critical that common issues
raised across groups are addressed centrally. Suggestions
by respondents largely fall into the categories (i) con-
ceptual and terminology issues, (ii) pragmatic guidance on
application of the GRADE approach and (iii) potential
modifications to the existing scheme for rating the quality
of evidence.Conceptual and terminology issues
We propose that the GRADE Working Group refine
and revise, where appropriate, current terminology and
definitions to make these more applicable to public
health interventions. In particular, this relates to the
interpretation of confidence in the evidence, the use of
terms such as patients and clinicians vs. beneficiaries
and practitioners/policy-makers, the definition and
classification of study designs, and the terminology
used to communicate quality of evidence and strength
of recommendation.
Efforts underway to address some of the issues raised
include, for example, public health-compatible GRADE
guidance on the meaning of outcomes that are critical
vs. important vs. of limited importance, and alternative
ways of communicating quality of evidence using sym-
bols such as ⊕⊕⊕Ο [38] or focusing on the likelihood
of further evidence to change conclusions [23,24]. The
GRADE Working Group has been flexible in the use of
terminology to express the quality of evidence (e.g. con-
fidence in effect estimates) and strength of recommen-
dation (e.g. “conditional recommendation” instead of
“weak recommendation”).
Pragmatic guidance on application of the GRADE approach
We propose that the GRADE Working Group develop
pragmatic guidance on how to apply the GRADE approach
to complex interventions, illustrated with public health
examples. In relation to rating the quality of evidence, gui-
dance should address how to ensure reproducibility and in-
ternal consistency, when to consider non-randomised
evidence in addition to randomised evidence, and how to
apply GRADE criteria to narrative summaries. In relation
to going from evidence to recommendations, guidance
should include public health-specific considerations that
influence the strength of a recommendation.
Current efforts include the DECIDE project, which aims
to improve the dissemination of evidence-based recom-
mendations by building on the work of the GRADE
Working Group [39]. For example, the DECIDE pro-
ject has expanded the GRADE framework for moving
from evidence to recommendations to include factors
such as the prevalence of the problem, incremental
cost relative to benefit, equity, feasibility and accep-
tability. There are also efforts by different groups to
make the assessment of value judgements, resource
use and feasibility more explicit and transparent [22].
The SUPPORT collaboration offers excellent guidance
and worked examples of how GRADE can be applied
to narrative summaries [40]. With respect to reprodu-
cibility, the GRADE Working Group acknowledges
that many steps in the process of rating the quality of
evidence are subjective and highlights the importance
of transparency in reporting these judgements. It is
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prove reliability of the methodology.Potential modifications to the existing scheme for rating
quality of evidence
We propose that the GRADE Working Group review
whether selected observational study designs should start
off as moderate and develop and test additional criteria
for upgrading, provided these can be made meaningful
and applicable across public health and clinical medicine.
The Working Group should also explore how other rele-
vant sources of evidence that do not follow the traditional
hierarchy of study designs (e.g. evidence generated by
other disciplines, modelling studies) can be integrated
with GRADE at the level of rating quality of evidence
and/or at the level of grading a recommendation. GRADE
should provide more explicit guidance about the use of
different types of evidence.
During regular meetings of the GRADE Working
Group, specific examples of problems encountered can
be raised and discussed, facilitating the continuous
evolvement of the GRADE approach. Such a discussion
led, for example, to agreement that the dose–response
relationship criterion can also be applied at the popula-
tion level [23,24]. Systematic reviews registered with the
Cochrane Collaboration’s Public Health Group and
guideline projects at the World Health Organization
provide ample opportunity for testing a revised grading
scheme.Conclusions
This empirical study reviewed current experience with
the GRADE approach in the field of public health. It
suggests that GRADE principles are applicable to public
health, and that the systematic, transparent and rigorous
nature of the process is well-received by those groups
who have applied it. It also identified several common
challenges, particularly in relation to evidence grading,
which was the focus of this study. Contributions from
respondents suggest that a combination of revisiting con-
cepts and terminology, providing better guidance on how
to apply GRADE to complex interventions and making
some modifications to the existing scheme for rating
quality of evidence could improve the applicability of the
GRADE approach to public health interventions. Our
proposal is intended as the starting point for a research
and development agenda to explore options for improve-
ments and, where applicable, to test these in systematic
reviews and guideline projects across different types of
public health interventions. Independent of whether the
specific challenges identified here are perceived or real,
they merit attention, if the GRADE approach is to be
more widely adopted in the public health world.Additional file
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